Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time.

Itamar AverbuchAssaf MooreEthan Bernard LudmirGal MarkelTomer Meirson

Published in: British journal of cancer (2024)

RMST demonstrates the efficacy of local treatment in OMD. Representing the expected survival time, this method effectively communicates outcomes to patients and clinicians.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
free survival
stem cells
type diabetes
patient reported outcomes
bone marrow
replacement therapy
smoking cessation